Ulcerative Colitis-induced Hematotoxicity in Mice and its Amelioration with Visnagin


24 / 12

Authors

  • V. Sravathi
  • D.Madhuri
  • Y. Ravikumar
  • B. Anil Kumar
  • A. Viayakumar
  • B. Swati
  • S. Soujanya

https://doi.org/10.62757/

Keywords:

Mice, Dextran sodium sulphate, Ulcerative colitis, Dexamethasone, Visnagin

Abstract

Ulcerative Colitis (UC) is the most challenging disease in humans and animals. The present study was done to explore the potential effect of Visnagin against Dextran Sodium Sulphate (DSS) induced UC in mice, and its potential mechanism. Visnagin, a natural compound, has a range of antioxidant and anti-inflammatory effects. The mice were euthanized on the 32nd day of the experimental period, and the haematological parameters were assessed to evaluate the efficacy of the treatment. The results indicated significant improvements in the haematological parameters, suggesting that visnagin can effectively mitigate the haematological impacts of DSS-induced ulcerative colitis in mice.

Downloads

Download data is not yet available.

References

Abou Zaid, E.S., S.Z. Mansour, S.M. El-Sonbaty,

F.S. Moawed, E.I. Kandil and R.A. Haroun (2023), Boswellic acid-coated zinc nanoparticles attenuate NF-κB-mediated inflammation in DSS-induced ulcerative colitis in rats, Int. J. Immunopathol. Pharmacol., 37(3): 1- 6.

Asnani, A., B. Zheng, Y. Liu, Y. Wang, H.H. Chen,

A. Vohra, A. Chi, I. Cornella-Taracido, H. Wang, D.G. Johns and D.E. Sosnovik (2018), Highly potent visnagin derivatives inhibit Cyp1 and prevent doxorubicin cardiotoxicity, JCI insight, 3(1): e96753.

Mack, D.R., B. Saul, B. Boyle, A. Griffiths, C. Sauer, J. Markowitz, N. LeLeiko, D. Keljo,

J.R. Rosh, S.S. Baker and S. Steiner (2020), Analysis of Using the Total White Blood Cell Count to Define Severe New‐onset Ulcerative Colitis in Children. JPGN, 71(3): 354-360.

Meineri, G., E. Martello, E. Radice, N. Bruni, V. Saettone, D. Atuahene, A. Armandi, G.

Testa and D.G. Ribaldone (2022), Chronic intestinal disorders in humans and pets: Current management and the potential of nutraceutical antioxidants as alternatives, Ani., 12(7): 812-820.

Panah, F. M., C. Lauridsen, O. Hojberg and T.S. Nielsen (2021), Etiology of colitis- complex diarrhoea in growing pigs: a review, Ani, 11(7): 2151-2157.

Pasari, L.P., A. Khurana, P. Anchi, M.A. Saifi, S. Annaldas and C. Godugu (2019), Visnagin attenuates acute pancreatitis via Nrf2/NFκB pathway and abrogates associated multiple organ dysfunction, Biomed Pharmacother., 112: 108629.

Shah, Y., D. Patel and N. Khan (2021), Iron deficiency anaemia in IBD: an overlooked comorbidity, Exper. Rev. Gastroenterol. Hepatol., 15(7): 771-781.

Zhdanava, M., R. Zhao, A.M. Manceur, Z. Ding,

J. Boudreau, S. Kachroo, C. Kerner, J. Izanec and D. Pilon (2024), Burden of chronic corticosteroid use among patients with ulcerative colitis initiated on targeted treatment or conventional therapy in the United States, JMCP, 30(2): 141-52.

Downloads

Submitted

2026-01-29

Published

2026-01-29

How to Cite

V. Sravathi, D.Madhuri, Y. Ravikumar, B. Anil Kumar, A. Viayakumar, B. Swati, & S. Soujanya. (2026). Ulcerative Colitis-induced Hematotoxicity in Mice and its Amelioration with Visnagin. The Indian Veterinary Journal, 102(1). https://doi.org/10.62757/